6fy0: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal structure of a V2-directed, RV144 vaccine-like antibody from HIV-1 infection, CAP228-16H, bound to a heterologous V2 peptide== | |||
<StructureSection load='6fy0' size='340' side='right' caption='[[6fy0]], [[Resolution|resolution]] 2.57Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6fy0]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1] and [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FY0 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6FY0 FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |||
[[Category: | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6fy0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6fy0 OCA], [http://pdbe.org/6fy0 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6fy0 RCSB], [http://www.ebi.ac.uk/pdbsum/6fy0 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6fy0 ProSAT]</span></td></tr> | ||
</table> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Human]] | |||
[[Category: Dirr, H W]] | |||
[[Category: Fernandes, M]] | |||
[[Category: Moore, P L]] | |||
[[Category: Morris, L]] | |||
[[Category: Sayed, Y]] | |||
[[Category: Vijayakumar, B]] | |||
[[Category: Wibmer, C K]] | |||
[[Category: Fab]] | |||
[[Category: Hiv v2 peptide]] | |||
[[Category: Immune system]] | |||
Revision as of 08:56, 19 December 2018
Crystal structure of a V2-directed, RV144 vaccine-like antibody from HIV-1 infection, CAP228-16H, bound to a heterologous V2 peptide
| ||||||||||||
